Literature DB >> 18404437

Ecto-5'-nucleotidase and intestinal ion secretion by enteropathogenic Escherichia coli.

John K Crane1, Irina Shulgina, Tonniele M Naeher.   

Abstract

Enteropathogenic Escherichia coli (EPEC) triggers a large release of adenosine triphosphate (ATP) from host intestinal cells and the extracellular ATP is broken down to adenosine diphosphate (ADP), AMP, and adenosine. Adenosine is a potent secretagogue in the small and large intestine. We suspected that ecto-5'-nucleotidase (CD73, an intestinal enzyme) was a critical enzyme involved in the conversion of AMP to adenosine and in the pathogenesis of EPEC diarrhea. We developed a nonradioactive method for measuring ecto-5'-nucleotidase in cultured T84 cell monolayers based on the detection of phosphate release from 5'-AMP. EPEC infection triggered a release of ecto-5'-nucleotidase from the cell surface into the supernatant medium. EPEC-induced 5'-nucleotidase release was not correlated with host cell death but instead with activation of phosphatidylinositol-specific phospholipase C (PI-PLC). Ecto-5'-nucleotidase was susceptible to inhibition by zinc acetate and by alpha,beta-methylene-adenosine diphosphate (alpha,beta-methylene-ADP). In the Ussing chamber, these inhibitors could reverse the chloride secretory responses triggered by 5'-AMP. In addition, alpha,beta-methylene-ADP and zinc blocked the ability of 5'-AMP to stimulate EPEC growth under nutrient-limited conditions in vitro. Ecto-5'-nucleotidase appears to be the major enzyme responsible for generation of adenosine from adenine nucleotides in the T84 cell line, and inhibitors of ecto-5'-nucleotidase, such as alpha,beta-methylene-ADP and zinc, might be useful for treatment of the watery diarrhea produced by EPEC infection.

Entities:  

Year:  2007        PMID: 18404437      PMCID: PMC2096642          DOI: 10.1007/s11302-007-9056-0

Source DB:  PubMed          Journal:  Purinergic Signal        ISSN: 1573-9538            Impact factor:   3.765


  49 in total

1.  Translocated EspF protein from enteropathogenic Escherichia coli disrupts host intestinal barrier function.

Authors:  B P McNamara; A Koutsouris; C B O'Connell; J P Nougayréde; M S Donnenberg; G Hecht
Journal:  J Clin Invest       Date:  2001-03       Impact factor: 14.808

2.  Ectonucleotide diphosphohydrolase activities in Entamoeba histolytica.

Authors:  F S Barros; L F De Menezes; A A Pinheiro; E F Silva; A H Lopes; W De Souza; J R Meyer-Fernandes
Journal:  Arch Biochem Biophys       Date:  2000-03-15       Impact factor: 4.013

3.  Ecto-5'-nucleotidase from a human colon adenocarcinoma cell line. Correlation between enzyme activity and levels in intact cells.

Authors:  J M Navarro; N Olmo; J Turnay; M T López-Conejo; M A Lizarbe
Journal:  Mol Cell Biochem       Date:  1998-10       Impact factor: 3.396

4.  Surface expression, polarization, and functional significance of CD73 in human intestinal epithelia.

Authors:  G R Strohmeier; W I Lencer; T W Patapoff; L F Thompson; S L Carlson; S J Moe; D K Carnes; R J Mrsny; J L Madara
Journal:  J Clin Invest       Date:  1997-06-01       Impact factor: 14.808

5.  Release of the glycosylphosphatidylinositol-anchored enzyme ecto-5'-nucleotidase by phospholipase C: catalytic activation and modulation by the lipid bilayer.

Authors:  M T Lehto; F J Sharom
Journal:  Biochem J       Date:  1998-05-15       Impact factor: 3.857

6.  The diarrheal response of humans to some classic serotypes of enteropathogenic Escherichia coli is dependent on a plasmid encoding an enteroadhesiveness factor.

Authors:  M M Levine; J P Nataro; H Karch; M M Baldini; J B Kaper; R E Black; M L Clements; A D O'Brien
Journal:  J Infect Dis       Date:  1985-09       Impact factor: 5.226

7.  Identification of a compound that directly stimulates phospholipase C activity.

Authors:  Yoe-Sik Bae; Taehoon G Lee; Jun Chul Park; Jung Ho Hur; Youndong Kim; Kyun Heo; Jong-Young Kwak; Pann-Ghill Suh; Sung Ho Ryu
Journal:  Mol Pharmacol       Date:  2003-05       Impact factor: 4.436

8.  Type IV pili, transient bacterial aggregates, and virulence of enteropathogenic Escherichia coli.

Authors:  D Bieber; S W Ramer; C Y Wu; W J Murray; T Tobe; R Fernandez; G K Schoolnik
Journal:  Science       Date:  1998-06-26       Impact factor: 47.728

9.  An ultrastructural study of enteropathogenic Escherichia coli infection in human infants.

Authors:  R J Rothbaum; J C Partin; K Saalfield; A J McAdams
Journal:  Ultrastruct Pathol       Date:  1983-06       Impact factor: 1.094

10.  Physiological roles for ecto-5'-nucleotidase (CD73).

Authors:  Sean P Colgan; Holger K Eltzschig; Tobias Eckle; Linda F Thompson
Journal:  Purinergic Signal       Date:  2006-06-01       Impact factor: 3.765

View more
  10 in total

1.  Intestinal Epithelial Ecto-5'-Nucleotidase (CD73) Regulates Intestinal Colonization and Infection by Nontyphoidal Salmonella.

Authors:  Daniel J Kao; Bejan J Saeedi; David Kitzenberg; Krista M Burney; Evgenia Dobrinskikh; Kayla D Battista; Andrés Vázquez-Torres; Sean P Colgan; Douglas J Kominsky
Journal:  Infect Immun       Date:  2017-09-20       Impact factor: 3.441

2.  Feedback effects of host-derived adenosine on enteropathogenic Escherichia coli.

Authors:  John K Crane; Irina Shulgina
Journal:  FEMS Immunol Med Microbiol       Date:  2009-08-18

3.  Biological Activities of Uric Acid in Infection Due to Enteropathogenic and Shiga-Toxigenic Escherichia coli.

Authors:  John K Crane; Jacqueline E Broome; Agnieszka Lis
Journal:  Infect Immun       Date:  2016-03-24       Impact factor: 3.441

Review 4.  Immunological alterations mediated by adenosine during host-microbial interactions.

Authors:  Ioannis Drygiannakis; Peter B Ernst; David Lowe; Ian J Glomski
Journal:  Immunol Res       Date:  2011-05       Impact factor: 2.829

5.  Effect of zinc in enteropathogenic Escherichia coli infection.

Authors:  John K Crane; Tonniele M Naeher; Irina Shulgina; Chengru Zhu; Edgar C Boedeker
Journal:  Infect Immun       Date:  2007-09-17       Impact factor: 3.441

6.  Recombinant ecto-5'-nucleotidase (CD73) has long lasting antinociceptive effects that are dependent on adenosine A1 receptor activation.

Authors:  Nathaniel A Sowa; Meagen K Voss; Mark J Zylka
Journal:  Mol Pain       Date:  2010-04-14       Impact factor: 3.395

7.  Role of host xanthine oxidase in infection due to enteropathogenic and Shiga-toxigenic Escherichia coli.

Authors:  John K Crane; Tonniele M Naeher; Jacqueline E Broome; Edgar C Boedeker
Journal:  Infect Immun       Date:  2013-01-22       Impact factor: 3.441

Review 8.  Enteric infection meets intestinal function: how bacterial pathogens cause diarrhoea.

Authors:  V K Viswanathan; Kim Hodges; Gail Hecht
Journal:  Nat Rev Microbiol       Date:  2008-12-31       Impact factor: 60.633

Review 9.  Uric acid extrarenal excretion: the gut microbiome as an evident yet understated factor in gout development.

Authors:  Eder Orlando Méndez-Salazar; Gabriela Angélica Martínez-Nava
Journal:  Rheumatol Int       Date:  2021-09-29       Impact factor: 2.631

10.  Mutual role of ecto-5'-nucleotidase/CD73 and concentrative nucleoside transporter 3 in the intestinal uptake of dAMP.

Authors:  Katsuya Narumi; Tsukika Ohata; Yuichi Horiuchi; Hiroshi Satoh; Ayako Furugen; Masaki Kobayashi; Ken Iseki
Journal:  PLoS One       Date:  2019-10-21       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.